McDermott Will & Emery has added two lawyers to its life sciences practice in Washington, including the top in-house counsel for AstraZeneca Pharmaceuticals LP, the firm announced Monday.
Glenn Engelmann, the former vice president and general counsel of AstraZeneca, and Susan Lee, a former Covington & Burling associate, have joined the firm as senior counsel and associate, respectively.
At AstraZeneca, Engelmann advised company leadership on a variety of legal and regulatory matters as well as defending federal and state investigations and patent challenges. Lee will serve as a Food and Drug Administration associate and advise on business planning, product development, product testing and clinical trials and submissions to the FDA.
Engelmann and Lee bring “unique insights and experiences that will enable the firm to better service the needs of our global clients,” Stephen Bernstein, head of the firm’s health industry advisory practice group, said in a written statement.